Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

469.34
-8.7900-1.84%
Post-market: 470.280.9400+0.20%19:57 EDT
Volume:1.10M
Turnover:518.21M
Market Cap:119.08B
PE:30.64
High:486.66
Open:481.79
Low:469.08
Close:478.13
52wk High:519.68
52wk Low:362.50
Shares:253.72M
Float Shares:253.72M
Volume Ratio:0.59
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):15.32
EPS(LYR):15.32
ROE:22.54%
ROA:12.16%
PB:6.38
PE(LYR):30.64

Loading ...

Vertex Pharmaceuticals Raised to Overweight From Equal-Weight by Barclays

Dow Jones
·
Jan 28

Vertex Pharmaceuticals assumed with Overweight from Equal Weight at Barclays

TIPRANKS
·
Jan 28

Vertex Pharmaceuticals (VRTX) Receives a Buy from Citi

TIPRANKS
·
Jan 27

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 27

Vertex Pharmaceuticals Is Maintained at Buy by UBS

Dow Jones
·
Jan 27

Vertex Pharmaceuticals price target raised to $545 from $535 at UBS

TIPRANKS
·
Jan 26

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Corcept Therapeutics (CORT), Intuitive Surgical (ISRG) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jan 23

Vertex Pharmaceuticals price target raised to $530 from $475 at Evercore ISI

TIPRANKS
·
Jan 23

Kimberly Clark, S&P Global, Exxon Mobil And A Health Care Stock On CNBC's 'Final Trades'

Benzinga_recent_news
·
Jan 23

Vertex Pharmaceuticals gets orphan status for membranous nephropathy treatment

TIPRANKS
·
Jan 23

Vertex Pharmaceuticals Poised for Higher Valuation on Povetacicept, Cystic Fibrosis Pipeline, RBC Says

MT Newswires Live
·
Jan 23

Vertex Pharmaceuticals Raised to Outperform From Sector Perform by RBC Capital

Dow Jones
·
Jan 22

RBC Upgrades Vertex Pharmaceuticals to Outperform From Sector Perform, Raises Price Target to $546 From $455

MT Newswires Live
·
Jan 22

Vertex upgraded to Outperform from Sector Perform at RBC Capital

TIPRANKS
·
Jan 22

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 22

Vortex Energy Advances Canadian Exploration Portfolio and Resets AGM to February

TIPRANKS
·
Jan 22

Vertex Pharmaceuticals Incorporated to Announce Fourth Quarter and Full Year 2025 Financial Results

Reuters
·
Jan 21

Analysts Have Conflicting Sentiments on These Healthcare Companies: HCA Healthcare (HCA), Vertex Pharmaceuticals (VRTX) and Roche Holding AG (OtherRHHVF)

TIPRANKS
·
Jan 20

Vertex Minerals Reports Final Sales Revenue of Over AU$300,000 for December 2025; Shares Down 4%

MT Newswires Live
·
Jan 16

Vertex Minerals Lifts Output at Reward Gold Mine as Higher-Grade Ore Flows Underground

TIPRANKS
·
Jan 16